-+ 0.00%
-+ 0.00%
-+ 0.00%

Egetis Therapeutics to Move to Nasdaq Stockholm's Mid Cap Segment

MT Newswires·12/18/2025 00:40:16
Listen to the news
12:40 AM EST, 12/18/2025 (MT Newswires) -- Egetis Therapeutics (EGTX.ST) will transition to the Nasdaq Stockholm's Mid Cap segment from the Small Cap segment, effective Jan. 2, 2026. The transfer follows the completion of an annual review of market cap segments by the bourse in November, the pharmaceutical company said Wednesday.